Zacks Research Has Weak Outlook for Neogen FY2025 Earnings

Neogen Co. (NASDAQ:NEOG - Free Report) - Stock analysts at Zacks Research lowered their FY2025 earnings per share (EPS) estimates for Neogen in a report released on Monday, May 5th. Zacks Research analyst R. Department now expects that the company will earn $0.30 per share for the year, down from their previous estimate of $0.32. The consensus estimate for Neogen's current full-year earnings is $0.38 per share.

Neogen (NASDAQ:NEOG - Get Free Report) last released its earnings results on Wednesday, April 9th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.02). Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The company had revenue of $221.00 million during the quarter, compared to analyst estimates of $225.27 million. During the same period in the previous year, the company posted $0.12 EPS. The company's quarterly revenue was down 3.4% compared to the same quarter last year.

A number of other equities research analysts have also commented on the company. Guggenheim dropped their price target on Neogen from $15.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, April 10th. Piper Sandler dropped their target price on Neogen from $6.40 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd.

Neogen Stock Up 1.7%

Shares of NASDAQ NEOG traded up $0.11 during mid-day trading on Thursday, reaching $6.61. 3,399,017 shares of the company's stock were exchanged, compared to its average volume of 5,040,763. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of -3.02 and a beta of 1.83. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33. The business has a fifty day simple moving average of $7.04 and a 200 day simple moving average of $10.54. Neogen has a twelve month low of $3.87 and a twelve month high of $18.58.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Raymond James Financial Inc. bought a new stake in Neogen in the 4th quarter valued at $2,744,000. Dimensional Fund Advisors LP lifted its position in shares of Neogen by 24.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,939,984 shares of the company's stock worth $84,254,000 after buying an additional 1,345,056 shares during the last quarter. Norges Bank bought a new stake in shares of Neogen during the 4th quarter worth $212,171,000. Vanguard Group Inc. lifted its position in shares of Neogen by 9.8% during the 4th quarter. Vanguard Group Inc. now owns 21,637,251 shares of the company's stock worth $262,676,000 after buying an additional 1,928,491 shares during the last quarter. Finally, Private Advisor Group LLC increased its holdings in Neogen by 135.3% in the 4th quarter. Private Advisor Group LLC now owns 67,298 shares of the company's stock worth $817,000 after purchasing an additional 38,703 shares in the last quarter. 96.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Neogen

In related news, CAO John Patrick Moylan purchased 10,000 shares of the stock in a transaction on Thursday, April 10th. The shares were purchased at an average price of $5.07 per share, with a total value of $50,700.00. Following the transaction, the chief accounting officer now directly owns 10,000 shares of the company's stock, valued at $50,700. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Aashima Gupta purchased 16,000 shares of the stock in a transaction on Monday, May 12th. The shares were bought at an average cost of $6.25 per share, for a total transaction of $100,000.00. Following the transaction, the director now directly owns 21,917 shares in the company, valued at approximately $136,981.25. The trade was a 270.41% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 83,500 shares of company stock valued at $431,525. 1.13% of the stock is owned by insiders.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.